IHS Markit on Feedspot

IHS Markit

151 FOLLOWERS

Find timely insights, commentary, and special reports from industry-leading experts and analysts. Industry insights from the IHS Markit Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

US EV sales grew nearly 52% in 2023. So why are automakers slowing EV investments?

IHS Markit

4M ago

Key takeaways: Customers are returning to the US market, with 16.5 million vehicle sales expected in 2025. EV sales in the US crossed the one-million mark for the first time in 2023, but EV growth is still slower than some automakers and industry observers anticipated The challenge for automakers over the next three years will be finding a way to offer a blend of ICE, hybrid, plug-in hybrid or battery electric solutions to meet their consumer needs Nearly 80 new product launches are expected in 2024 (both ICE and EV) - more than double 2023 and resulting in about 385 models for US consumers t ..read more

Visit website

How to democratize access and prevent the next supermodel medicine

IHS Markit

3y ago

Visit website

United States experience dramatic shift in public share of healthcare spending

IHS Markit

3y ago

Visit website

Norwegian pharma industry calls for tendering and IRP reforms